Synthekine

Developer of cytokine therapeutics

placeMenlo Park, California, United States calendar_todayFounded 2018 groups104 employees language synthekine.com

Innovation

46 patent families (18 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 4,750 times.

YearFilings
20217
202229
202334
202428
202526
202610

Social engagement

Social engagement: 9.1K social following, 4 posts in the last 12 months — below the industry typical range.

Investor mix

12 investors on record; lead investors include Canaan, Samsara BioCapital, The Column Group, Janus Henderson Investors.

Investor typeCountShare
Venture capital867%
Bank & private debt18%
Other / undisclosed325%

Recent activity

12 Nov 2025
Event
SITC Annual Meeting segment on BiotechTV
30 Oct 2025
Event
SITC annual meeting
Coming soon